These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 16720085)
1. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors. Katragadda S; Talluri RS; Mitra AK Int J Pharm; 2006 Aug; 320(1-2):104-13. PubMed ID: 16720085 [TBL] [Abstract][Full Text] [Related]
2. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits. Anand BS; Katragadda S; Gunda S; Mitra AK Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437 [TBL] [Abstract][Full Text] [Related]
3. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium. Anand BS; Katragadda S; Nashed YE; Mitra AK Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism. Anand BS; Katragadda S; Mitra AK J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381 [TBL] [Abstract][Full Text] [Related]
5. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. Tak RV; Pal D; Gao H; Dey S; Mitra AK J Pharm Sci; 2001 Oct; 90(10):1505-15. PubMed ID: 11745709 [TBL] [Abstract][Full Text] [Related]
6. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea. Anand B; Nashed Y; Mitra A Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543 [TBL] [Abstract][Full Text] [Related]
7. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2. Anand BS; Patel J; Mitra AK J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834 [TBL] [Abstract][Full Text] [Related]
8. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line. Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea. Anand BS; Mitra AK Pharm Res; 2002 Aug; 19(8):1194-202. PubMed ID: 12240946 [TBL] [Abstract][Full Text] [Related]
10. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter. Han HK; Oh DM; Amidon GL Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889 [TBL] [Abstract][Full Text] [Related]
11. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Balimane PV; Tamai I; Guo A; Nakanishi T; Kitada H; Leibach FH; Tsuji A; Sinko PJ Biochem Biophys Res Commun; 1998 Sep; 250(2):246-51. PubMed ID: 9753615 [TBL] [Abstract][Full Text] [Related]
12. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme. Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376 [TBL] [Abstract][Full Text] [Related]
13. Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Jain-Vakkalagadda B; Pal D; Gunda S; Nashed Y; Ganapathy V; Mitra AK Mol Pharm; 2004; 1(5):338-46. PubMed ID: 16026003 [TBL] [Abstract][Full Text] [Related]
14. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats. Sinko PJ; Balimane PV Biopharm Drug Dispos; 1998 May; 19(4):209-17. PubMed ID: 9604120 [TBL] [Abstract][Full Text] [Related]
16. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. Katragadda S; Gunda S; Hariharan S; Mitra AK Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234 [TBL] [Abstract][Full Text] [Related]
17. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model. Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053 [TBL] [Abstract][Full Text] [Related]
18. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043 [TBL] [Abstract][Full Text] [Related]
19. Effect of oral valaciclovir on herpetic keratitis. Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a Na+-dependent neutral amino acid transporter, ASCT1, in rabbit corneal epithelial cell culture and rabbit cornea. Katragadda S; Talluri RS; Pal D; Mitra AK Curr Eye Res; 2005 Nov; 30(11):989-1002. PubMed ID: 16282133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]